In reference to Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy (Laryngoscope 119:359-369, 2009)

Laryngoscope. 2009 Dec;119(12):2480; author reply 2481-2. doi: 10.1002/lary.20599.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Catheterization / methods*
  • Dexamethasone / administration & dosage*
  • Double-Blind Method
  • Drug Administration Routes
  • Glucocorticoids / administration & dosage*
  • Hearing Loss, Sensorineural / drug therapy*
  • Hearing Loss, Sudden / drug therapy*
  • Humans
  • Randomized Controlled Trials as Topic
  • Round Window, Ear
  • Treatment Outcome
  • Tympanic Membrane

Substances

  • Glucocorticoids
  • Dexamethasone